Mitochondria‐targeted esculetin inhibits PAI‐1 levels by modulating STAT3 activation and miR‐19b via SIRT3: Role in acute coronary artery syndrome

Sujana Katta(Indian Institute of Chemical Technology), Srigiridhar Kotamraju(Academy of Scientific and Innovative Research)

Journal of Cellular Physiology

February 18, 2017

10.1002/jcp.25865

Cited by 34

Related Papers

Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis

|Scientific Reports|2016|60

Fluvastatin Mediated Breast Cancer Cell Death: A Proteomic Approach to Identify Differentially Regulated Proteins in MDA-MB-231 Cells

|PLoS ONE|2014|22